NDC 83027-0156 – Virex

Asclepias Tuberosa Root 3 [hp_X]/mL; Echinacea Purpurea Whole 3 [hp_X]/mL; Trifolium Pratense Flower 3 [hp_X]/mL; Sodium Chloride 4 [hp_X]/mL; Phytolacca… · Spray · Oral

Human Otc Drug

Product NDC83027-0156

Product details

Brand name
Virex
Generic name
Adenoviren Nosode, Asclepias Tuberosa, Calcarea Arsenicica, Camphora, Coxsackie A2 Nosode, Coxsackie A3 Nosode, Coxsackie A4 Nosode, Coxsackie A5 Nosode, Coxsackie A7 Nosode, Coxsackie B1 Nosode, Coxsackie B3 Nosode, Coxsackie B4 Nosode, Coxsackie B5 Nosode, Cytomegalovirus Nosode, Echinacea Purpurea, Epstein-Barr Virus Nosode, Euphrasia Officinalis, Influenzinum, Lac Vaccinum, Morbillinum, Natrum Muriaticum, Phytolacca Decandra, Thuja Occidentalis, Trifolium Pratense, Variolinum
Labeler
Nutritional Specialties, Inc.
Dosage form
Spray
Route
Oral
Marketing category
UNAPPROVED HOMEOPATHIC
Marketed since
October 3, 2025
Listing expires
December 31, 2026
Pharmacologic class
Live Human Adenovirus Type 4 Vaccine; Non-Standardized Food Allergenic Extract

Active ingredients

Uses, dosage, side effects and warnings for Virex →

Package NDC codes (1)

Package NDCDescriptionSince
83027-0156-160 mL in 1 BOTTLE, SPRAY (83027-0156-1)Oct 3, 2025

Other Virex products